glycerol has been researched along with Chronic Disease in 63 studies
Moon: The natural satellite of the planet Earth. It includes the lunar cycles or phases, the lunar month, lunar landscapes, geography, and soil.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "It has been reported that therapy with iodinated glycerol (IG) can improve the quality of life for patients with chronic bronchitis." | 9.08 | Iodinated glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis. ( Ohar, JA; Ramirez, O; Rubin, BK, 1996) |
| "A total of 15 patients suffering from chronic low back pain were treated with an intradiscal injection of either 1 ml of 50% glycerol or 2 ml of 0." | 9.08 | Intradiscal glycerol or bupivacaine in the treatment of low back pain. ( Kirvelä, O; Kotilainen, E; Muittari, P, 1997) |
| "In a double-blind trial, 29 patients were treated for stable, chronic bronchitis with iodinated glycerol (Organidin, 60 mg four times daily; n = 16) or placebo (n = 13)." | 9.07 | Treatment of stable chronic bronchitis with iodinated glycerol: a double-blind, placebo-controlled trial. ( Repsher, LH, 1993) |
| "Seventy-four pulmonologists and one allergist were recruited to assess the efficacy and safety of iodinated glycerol (Organidin), 60 mg qid, vs placebo in patients with stable chronic obstructive bronchitis in a randomized, double-blind, placebo-controlled, parallel design." | 9.06 | The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis. ( Petty, TL, 1990) |
| "Glycerol is a known agent in the therapy of chronic tic douloureux." | 5.30 | Glycerol gangliotomy of the second dorsal cervical root in rats: an experimental study to evaluate a minimal invasive approach for the treatment of the chronic cervicogenic headache. ( Jansen, J; Kolle, M; Ludwig, HC, 1998) |
| "It has been reported that therapy with iodinated glycerol (IG) can improve the quality of life for patients with chronic bronchitis." | 5.08 | Iodinated glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis. ( Ohar, JA; Ramirez, O; Rubin, BK, 1996) |
| "A total of 15 patients suffering from chronic low back pain were treated with an intradiscal injection of either 1 ml of 50% glycerol or 2 ml of 0." | 5.08 | Intradiscal glycerol or bupivacaine in the treatment of low back pain. ( Kirvelä, O; Kotilainen, E; Muittari, P, 1997) |
| "In a double-blind trial, 29 patients were treated for stable, chronic bronchitis with iodinated glycerol (Organidin, 60 mg four times daily; n = 16) or placebo (n = 13)." | 5.07 | Treatment of stable chronic bronchitis with iodinated glycerol: a double-blind, placebo-controlled trial. ( Repsher, LH, 1993) |
| "Seventy-four pulmonologists and one allergist were recruited to assess the efficacy and safety of iodinated glycerol (Organidin), 60 mg qid, vs placebo in patients with stable chronic obstructive bronchitis in a randomized, double-blind, placebo-controlled, parallel design." | 5.06 | The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis. ( Petty, TL, 1990) |
| " In this latter group, otitis media was induced by injecting glycerin into the middle ear clefts 1 months after birth, and the degree of inflammation was varied by administering or withholding antibiotics (cefamandole and dibekacin) and adjusting the dosage regimen." | 3.69 | The relationship between the degree of chronic middle ear inflammation and tympanic bulla pneumatization in the pig as animal model. ( Ikarashi, F; Nakano, Y; Okura, T, 1994) |
| "In glycerol-induced acute renal failure, a model of rhabdomyolysis, clusterin mRNA was markedly increased 24 hours after injection of glycerol (control 97 +/- 21 versus glycerol 3644 +/- 134 optical density units; p < 0." | 3.69 | Induction of clusterin in acute and chronic oxidative renal disease in the rat and its dissociation from cell injury. ( Correa-Rotter, R; Dvergsten, J; Hostetter, TH; Manivel, JC; Nath, KA; Rosenberg, ME, 1994) |
| " Kidney damage was induced by both chemical (glycerol, cisplatin, or methotrexate) and mechanical (through renal artery clamping to produce unilateral renal ischemia) treatments." | 3.68 | Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration. ( Atencio, IA; Shadan, FF; Vaziri, ND; Villarreal, LP; Zhou, XJ, 1993) |
| "The glycerol ointment was the only treatment statistically better than both 'no treatment' and vehicle." | 2.72 | Anti-irritants II: Efficacy against cumulative irritation. ( Andersen, F; Andersen, KE; Bindslev-Jensen, C; Fullerton, A; Hedegaard, K; Petersen, TK, 2006) |
| "Twenty-seven adults with cancer pain were prospectively selected according to their primary lesions and problems, but their allocation to study groups was randomized." | 2.67 | Prolongation of epidural bupivacaine analgesia with glycerin. ( King, H; Wooten, DJ; Xiao, CS, 1993) |
| "Chronic pruritus is a common problem in patients with inflammatory skin diseases as well as in subjects with dry or sensitive skin." | 2.53 | Itch Management: Topical Agents. ( Metz, M; Staubach, P, 2016) |
| "Takotsubo cardiomyopathy is a cardiac syndrome characterized by transient left ventricular dysfunction." | 1.37 | [Case of Takotsubo cardiomyopathy after induction of general anesthesia]. ( Kakiuchi, H; Komasawa, N; Nakamoto, S; Noma, H; Sugi, T; Sukenaga, N; Tokuoka, T, 2011) |
| "In particular, lower back pain is very common and represents a significant burden both in terms of patient suffering and costs." | 1.36 | Treatment of chronic low-back pain: a 1-year or greater follow-up. ( Shay, BL; Watson, JD, 2010) |
| "Glycerol was significantly lower in the leg than in the pectoral region." | 1.32 | Microdialysate metabolites before, during and after vascular surgery for chronic leg ischaemia. ( Danielsson, P; Lundberg, CJ; Metzsch, C; Norgren, L, 2003) |
| "Glycerol is a known agent in the therapy of chronic tic douloureux." | 1.30 | Glycerol gangliotomy of the second dorsal cervical root in rats: an experimental study to evaluate a minimal invasive approach for the treatment of the chronic cervicogenic headache. ( Jansen, J; Kolle, M; Ludwig, HC, 1998) |
| "Medical treatment of chronic cluster headaches (cluster headaches that occur frequently without remission) can be very difficult." | 1.28 | Trigeminal cisternal injection of glycerol for treatment of chronic intractable cluster headaches. ( Covington, EC; Hassenbusch, SJ; Kosmorsky, GS; Kunkel, RS; Pillay, PK, 1991) |
| "Seven therapy-resistant patients with cluster headache (six of whom were chronic) were treated by percutaneous retro-Gasserian glycerol injections under general anesthesia." | 1.27 | Retro-Gasserian glycerol injection in the treatment of chronic cluster headache. ( Ekbom, K; Hardebo, JE; Lindgren, L; Nilsson, BY; Waldenlind, E, 1987) |
| "The chronicity of seborrheic dermatitis must be explained carefully to the patient and the necessity for avoiding water, cosmetics and other materials must be stressed." | 1.26 | Management of the ear canal seborrhea with cerumen. ( Storrs, LA, 1981) |
| "The effects of acute and chronic hypoxemia on norepinephrine-stimulated lipolysis were studied in dogs." | 1.26 | Norepinephrine-stimulated lipolysis in acute and chronic hypoxemia. ( Baum, D; Oyer, P, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (36.51) | 18.7374 |
| 1990's | 20 (31.75) | 18.2507 |
| 2000's | 11 (17.46) | 29.6817 |
| 2010's | 7 (11.11) | 24.3611 |
| 2020's | 2 (3.17) | 2.80 |
| Authors | Studies |
|---|---|
| Connor, S | 1 |
| Sierra-Arango, F | 1 |
| de la Hoz-Valle, J | 1 |
| Espinosa, JP | 1 |
| Moreno-Montoya, J | 1 |
| Vásquez Roldan, M | 1 |
| Pérez-Riveros, ED | 1 |
| Nair, HKR | 1 |
| Szabó, T | 1 |
| Postrach, E | 1 |
| Mähler, A | 1 |
| Kung, T | 1 |
| Turhan, G | 1 |
| von Haehling, S | 1 |
| Anker, SD | 1 |
| Boschmann, M | 1 |
| Doehner, W | 1 |
| Metz, M | 1 |
| Staubach, P | 1 |
| Watson, JD | 1 |
| Shay, BL | 1 |
| Sukenaga, N | 1 |
| Noma, H | 1 |
| Komasawa, N | 1 |
| Sugi, T | 1 |
| Nakamoto, S | 1 |
| Tokuoka, T | 1 |
| Kakiuchi, H | 1 |
| Sundback, CA | 1 |
| McFadden, J | 1 |
| Hart, A | 1 |
| Kulig, KM | 1 |
| Wieland, AM | 1 |
| Pereira, MJ | 1 |
| Pomerantseva, I | 1 |
| Hartnick, CJ | 1 |
| Masiakos, PT | 1 |
| Boateng, JS | 1 |
| Pawar, HV | 1 |
| Tetteh, J | 1 |
| Metzsch, C | 1 |
| Lundberg, CJ | 1 |
| Danielsson, P | 1 |
| Norgren, L | 1 |
| SPARKES, HD | 1 |
| Yelland, MJ | 2 |
| Mar, C | 1 |
| Pirozzo, S | 1 |
| Schoene, ML | 2 |
| Vercoe, P | 1 |
| Andersen, F | 1 |
| Hedegaard, K | 1 |
| Petersen, TK | 1 |
| Bindslev-Jensen, C | 1 |
| Fullerton, A | 1 |
| Andersen, KE | 1 |
| Ikeda, S | 2 |
| Dagenais, S | 1 |
| Del Mar, C | 1 |
| Fullerton, BD | 1 |
| Storrs, LA | 1 |
| Meyerson, BA | 1 |
| Baum, D | 1 |
| Oyer, P | 1 |
| McCulloch, JM | 1 |
| Marler, KC | 1 |
| Neal, MB | 1 |
| Phifer, TJ | 1 |
| Ikarashi, F | 1 |
| Nakano, Y | 1 |
| Okura, T | 1 |
| Blackman, JD | 1 |
| Senseng, D | 1 |
| Quinn, L | 1 |
| Mazzone, T | 1 |
| Nath, KA | 2 |
| Dvergsten, J | 1 |
| Correa-Rotter, R | 1 |
| Hostetter, TH | 1 |
| Manivel, JC | 1 |
| Rosenberg, ME | 1 |
| Vernick, SH | 1 |
| Shaw, FD | 1 |
| Lippmann, HI | 1 |
| Fishman, LM | 1 |
| Farrar, RH | 1 |
| Bernstein, RK | 1 |
| Zybert, PA | 1 |
| Goldstein, RE | 1 |
| Cherrington, AD | 1 |
| Reed, GW | 1 |
| Lacy, DB | 1 |
| Wasserman, DH | 1 |
| Abumrad, NN | 1 |
| Repsher, LH | 1 |
| Riley, M | 1 |
| Bell, N | 1 |
| Elborn, JS | 1 |
| Stanford, CF | 1 |
| Buchanan, KD | 1 |
| Nicholls, DP | 1 |
| Atencio, IA | 1 |
| Shadan, FF | 1 |
| Zhou, XJ | 1 |
| Vaziri, ND | 1 |
| Villarreal, LP | 1 |
| King, H | 1 |
| Xiao, CS | 1 |
| Wooten, DJ | 1 |
| Rubin, BK | 1 |
| Ramirez, O | 1 |
| Ohar, JA | 1 |
| Setton-Avruj, CP | 1 |
| Sterin-Speziale, NB | 1 |
| Kotilainen, E | 1 |
| Muittari, P | 1 |
| Kirvelä, O | 1 |
| Ludwig, HC | 1 |
| Kolle, M | 1 |
| Jansen, J | 1 |
| Dechow, E | 1 |
| Davies, RK | 1 |
| Carr, AJ | 1 |
| Thompson, PW | 1 |
| Bergan, JJ | 1 |
| Sparks, SR | 1 |
| Croatt, AJ | 1 |
| Haggard, JJ | 1 |
| Grande, JP | 1 |
| Fowler, JF | 1 |
| Bruley Des Varannes, S | 1 |
| Lehur, PA | 1 |
| Segel, LD | 1 |
| Rendig, SV | 1 |
| Choquet, Y | 1 |
| Chacko, K | 1 |
| Amsterdam, EA | 1 |
| Mason, DT | 1 |
| Wilensky, MC | 1 |
| Aurnhammer, W | 1 |
| Konietzko, N | 1 |
| Matthys, H | 1 |
| Ilinov, P | 1 |
| Nedelcheva, I | 1 |
| Goranov, I | 1 |
| Bultitude, FW | 1 |
| Newham, SJ | 1 |
| Yamashita, T | 1 |
| Eguchi, Y | 1 |
| Kashiwagi, S | 1 |
| Takasago, T | 1 |
| Nakano, S | 1 |
| Hayashi, M | 1 |
| Urakawa, M | 1 |
| Shiroyama, Y | 1 |
| Ito, H | 1 |
| Hassenbusch, SJ | 1 |
| Kunkel, RS | 1 |
| Kosmorsky, GS | 1 |
| Covington, EC | 1 |
| Pillay, PK | 1 |
| Tani, T | 1 |
| Tsuchihashi, Y | 1 |
| Yorioka, S | 1 |
| Maruyama, K | 1 |
| Mitsuhuzi, S | 1 |
| Tokita, K | 1 |
| Kodama, T | 1 |
| Oka, T | 1 |
| Ashihara, T | 1 |
| Petty, TL | 1 |
| Nishimura, K | 1 |
| Hayashi, C | 1 |
| Iwanaga, H | 1 |
| Tanaka, M | 1 |
| Tabuchi, K | 1 |
| Ekbom, K | 1 |
| Lindgren, L | 1 |
| Nilsson, BY | 1 |
| Hardebo, JE | 1 |
| Waldenlind, E | 1 |
| Pavia, D | 1 |
| Agnew, JE | 1 |
| Glassman, JM | 1 |
| Sutton, PP | 1 |
| Lopez-Vidriero, MT | 1 |
| Soyka, JP | 1 |
| Clarke, SW | 1 |
| Gericke, C | 1 |
| Rudorff, KH | 1 |
| Bartsch, G | 1 |
| Löhr, JP | 1 |
| Staib, W | 1 |
| Lefebvre, PJ | 1 |
| Sodoyez, JC | 1 |
| Luyckx, AS | 1 |
| Foà, PP | 1 |
| Raptis, S | 1 |
| Dollinger, H | 1 |
| Rothenbuchner, G | 1 |
| Fussgänger, R | 1 |
| Klör, U | 1 |
| Pfeiffer, EF | 1 |
| Buchin, PI | 1 |
| Dosychev, EA | 1 |
| Maslikov, VG | 1 |
| Chodosh, S | 1 |
| Alberti, KG | 1 |
| Record, CO | 1 |
| Williamson, DH | 1 |
| Wright, R | 1 |
| Cook, GC | 1 |
| Hayes, JM | 1 |
| Boonshaft, B | 1 |
| Maher, JF | 1 |
| O'Connell, JM | 1 |
| Schreiner, GE | 1 |
| Avasthi, P | 1 |
| Sharma, SD | 1 |
| Luthra, MC | 1 |
| Payrau, P | 1 |
| Dohlman, CH | 1 |
| Reissert, K | 1 |
| Rudas, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Rotator Cuff Tendinopathy: A Randomized and Blinded Comparison of Superficial and Deep Injection Methods[NCT01402011] | 77 participants (Actual) | Interventional | 2010-11-30 | Completed | |||
| Intermittent Pneumatic Compression of the Thigh for the Treatment of Lower Limb Wounds: a Randomised Control Trial[NCT05659394] | 160 participants (Anticipated) | Interventional | 2023-01-25 | Recruiting | |||
| Prospective Randomized Trial of Polymem vs. Bacitracin/Xeroform for Superficial Second Degree Burns[NCT00479193] | Phase 1 | 0 participants (Actual) | Interventional | 2006-10-31 | Withdrawn | ||
| The Efficacy of Prolotherapy in Osteoarthritic Knee Pain[NCT00085722] | Phase 1/Phase 2 | 98 participants (Actual) | Interventional | 2004-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Participants were asked about pain at rest, at work, doing sports. The maximum pain reported on a scale ranging from 0 (no pain at all) to 10 (extreme pain) was recorded for each participant. Maximum of pain scores rest, work, sport recorded. Calculated as pain at baseline - pain at 9 months. (NCT01402011)
Timeframe: baseline and 9 months
| Intervention | units on a scale (Mean) |
|---|---|
| 25% Dextrose in Ligaments and Tendons | 2.9 |
| .1% Lidocaine in Ligaments and Tendons | 1.8 |
| .1% Lidocaine Subcutaneous | 1.3 |
Subject marks his pain level at rest, at work, doing sports on a 10 cm scale. Maximum of pain scores rest, work, sport recorded. Calculated as pain at baseline - pain at 3 months. VAS scale is from 0 = no pain to 10 = maximum pain (NCT01402011)
Timeframe: baseline and three months
| Intervention | units on a scale (Mean) |
|---|---|
| 25% Dextrose in Ligaments and Tendons | 3.0 |
| .1% Lidocaine in Ligaments and Tendons | 2.7 |
| .1% Lidocaine Subcutaneous | 2.7 |
Phone call asking how satisfied were they with their treatment 10 = extremely satisfied, 0 = extremely dissatisfied ) (NCT01402011)
Timeframe: Nine months after first injection treatment appointment
| Intervention | units on a scale (Mean) |
|---|---|
| 25% Dextrose in Ligaments and Tendons | 6.7 |
| .1% Lidocaine in Ligaments and Tendons | 4.7 |
| .1% Lidocaine Subcutaneous | 3.9 |
Subject marks his pain level at rest, at work, doing sports on a 10 cm scale. The maximum pain level among the 3 different activities was recorded. (NCT01402011)
Timeframe: 20 minutes before first injection on first day of patient visit
| Intervention | units on a scale (Mean) |
|---|---|
| 25% Dextrose in Shoulder Entheses | 7.3 |
| .1% Lidocaine in Shoulder Entheses | 6.9 |
| .1% Lidocaine Subcu. Above Shouldr Enth. | 6.9 |
http://www.dash.iwh.on.ca/assets/images/pdfs/DASH_quest06.pdf 30 questions assessing ability to use shoulder in everyday activities, each question scored 1 to 5, where one is normal, no problem and five is unable to perform. No data was collected at 9 months. The score ranges from 30 to 150. Higher scores represent worse outcomes. (NCT01402011)
Timeframe: 20 minutes before the first injection and at 3 months
| Intervention | units on a scale (Mean) | |
|---|---|---|
| Baseline | 3 months | |
| .1% Lidocaine in Ligaments and Tendons | 71.3 | 54.7 |
| .1% Lidocaine Subcutaneous | 69.6 | 61 |
| 25% Dextrose in Ligaments and Tendons | 72.4 | 61.3 |
From Steven W. Brose, DO, Michael L. Boninger, MD, Bradley Fullerton, MD, Thane McCann, MD, From: Jennifer L. Collinger, BSE, Bradley G. Impink, BSE, Trevor A. Dyson-Hudson, MD Shoulder ultrasound abnormalities, physical examination findings, and pain in manual wheelchair users with spinal cord injury. Arch Phys Med Rehabil 2008 Nov; 89:2086-93, appendix 1 12 parameters of shoulder examination: Biceps tendon/bicipital groove tenderness, Supraspinatus tendon/greater tuberosity tenderness Acromioclavicular joint tenderness Resisted external rotation. Resisted internal rotation. Supraspinatus test. Painful Arc Test. Neer impingement sign. Hawkins-Kennedy impingement sign. O'Brien Active Compression Test for AC Joint Pathology O'Brien Active Compression Test for Labral Pathology impingement sign. each test scored 0 = no pain, 1 = tenderness, 2 = pain. All 12 scores added. Range 0-24. Higher scores = more pathology (NCT01402011)
Timeframe: 20 minutes before first injection on first day of patient visit and at 3 months
| Intervention | units on a scale (Mean) | |
|---|---|---|
| Baseline | 3 months | |
| .1% Lidocaine in Ligaments and Tendons | 13.1 | 10.7 |
| .1% Lidocaine Subcutaneous | 13 | 12.9 |
| 25% Dextrose in Ligaments and Tendons | 13.2 | 11.4 |
"From Brose et al. shoulder ultrasound abnormalities, physical examination findings, and pain in manual wheelchair users with spinal cord injury Arch Phys Med Rehabil 2008 Nov, 89: 2086-93 appendix 2. rates biceps tendinopathy (0-6), supraspinatus tendinopathy (0-5), greater tuberosity the cortical surface (0-3), dynamics supraspinatus impingement (0-3), dynamic subscapularis/ biceps/ coracoid impingement (0-3). The total score ranged from 0 to 20 with higher scores indicating a worse outcome. The change was calculated by taking the final score - the baseline score." (NCT01402011)
Timeframe: 20 minutes before first injection on first day of patient visit and at on average 9.4 months
| Intervention | units on a scale (Mean) | |
|---|---|---|
| Baseline | change at 9.4 +/- 2.2 months | |
| .1% Lidocaine in Ligaments and Tendons | 4.3 | -0.6 |
| .1% Lidocaine Subcutaneous | 4.3 | -0.6 |
| 25% Dextrose in Ligaments and Tendons | 4.0 | -0.3 |
9 reviews available for glycerol and Chronic Disease
| Article | Year |
|---|---|
Clinical Outcomes of Medical Management Options for Chronic Anal Fissures in a Long-Term Follow-up: Systematic Review and Meta-Analysis.
Topics: Adult; Chronic Disease; Fissure in Ano; Glycerol; Humans; Nifedipine; Nitroglycerin; Treatment Outco | 2023 |
Itch Management: Topical Agents.
Topics: Administration, Cutaneous; Analgesics, Opioid; Anesthetics, Local; Antipruritics; Camphor; Cannabino | 2016 |
Prolotherapy injections for chronic low-back pain.
Topics: Chronic Disease; Combined Modality Therapy; Exercise Therapy; Glucose; Glycerol; Humans; Injections; | 2004 |
[Adult-onset citrullinemia].
Topics: Administration, Oral; Age of Onset; Arginine; Argininosuccinate Synthase; Calcium-Binding Proteins; | 2007 |
[Adult-onset citrullinemia].
Topics: Administration, Oral; Adult; Age of Onset; Arginine; Argininosuccinate Synthase; Calcium-Binding Pro | 2007 |
Prolotherapy injections for chronic low-back pain.
Topics: Chronic Disease; Combined Modality Therapy; Exercise Therapy; Glucose; Glycerol; Humans; Injections; | 2007 |
Non-elastic compression: an alternative in management of chronic venous insufficiency.
Topics: Bandages; Chronic Disease; Drug Combinations; Evidence-Based Medicine; Gelatin; Glycerol; Humans; Sk | 2000 |
[Treatment of idiopathic constipation].
Topics: Biofeedback, Psychology; Bisacodyl; Cathartics; Chronic Disease; Colectomy; Colon, Sigmoid; Constipa | 2001 |
Newer drugs in the treatment of chronic bronchitis.
Topics: Acetylcysteine; Ampicillin; Anti-Bacterial Agents; Antitussive Agents; Bronchitis; Chronic Disease; | 1967 |
11 trials available for glycerol and Chronic Disease
| Article | Year |
|---|---|
Anti-irritants II: Efficacy against cumulative irritation.
Topics: Adult; Chemistry, Pharmaceutical; Chronic Disease; Dermatitis, Irritant; Dose-Response Relationship, | 2006 |
Intermittent pneumatic compression improves venous ulcer healing.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Bandages; Chronic Disease; Drug Therapy, Combina | 1994 |
Clinical evaluation of a semipermeable polymeric membrane dressing for the treatment of chronic diabetic foot ulcers.
Topics: Chronic Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Foot; Female; Glycer | 1994 |
Treatment of stable chronic bronchitis with iodinated glycerol: a double-blind, placebo-controlled trial.
Topics: Adult; Bronchitis; Chronic Disease; Cough; Double-Blind Method; Expectorants; Female; Glycerol; Huma | 1993 |
Prolongation of epidural bupivacaine analgesia with glycerin.
Topics: Aged; Analgesia, Epidural; Bupivacaine; Chronic Disease; Delayed-Action Preparations; Female; Glycer | 1993 |
Iodinated glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis.
Topics: Adult; Bronchitis; Chronic Disease; Cross-Over Studies; Double-Blind Method; Expectorants; Glycerol; | 1996 |
Intradiscal glycerol or bupivacaine in the treatment of low back pain.
Topics: Adult; Anesthetics, Local; Bupivacaine; Chronic Disease; Cryoprotective Agents; Female; Glycerol; Hu | 1997 |
A randomized, double-blind, placebo-controlled trial of sclerosing injections in patients with chronic low back pain.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Chronic Disease; Double-Blind Method; Female; Glucose | 1999 |
Problems in evaluating the effect of secretolytic agents on the mucociliary system by means of radioactive particles.
Topics: Airway Obstruction; Airway Resistance; Bromhexine; Bronchi; Bronchitis; Chronic Disease; Clinical Tr | 1977 |
The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis.
Topics: Adult; Aged; Aged, 80 and over; Bronchitis; Chronic Disease; Double-Blind Method; Female; Glycerol; | 1990 |
Effects of iodopropylidene glycerol on tracheobronchial clearance in stable, chronic bronchitic patients.
Topics: Aged; Bronchi; Bronchitis; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Expectora | 1985 |
43 other studies available for glycerol and Chronic Disease
| Article | Year |
|---|---|
Could glycerol levels be the key to unlocking the secret of post pancreatoduodenectomy acute pancreatitis?
Topics: Acute Disease; Chronic Disease; Glycerol; Humans; Pancreaticoduodenectomy; Pancreatitis; Postoperati | 2022 |
Fifty-Patient Study Evaluating the Efficacy of Modified Collagen With Glycerin in Periwound Skin Management.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Chronic Disease; Collagen; Compression Band | 2018 |
Increased catabolic activity in adipose tissue of patients with chronic heart failure.
Topics: Adipose Tissue; Adult; Aged; Atrial Natriuretic Factor; Blood Glucose; Cachexia; Case-Control Studie | 2013 |
Treatment of chronic low-back pain: a 1-year or greater follow-up.
Topics: Adult; Chronic Disease; Complementary Therapies; Female; Follow-Up Studies; Glucose; Glycerol; Human | 2010 |
[Case of Takotsubo cardiomyopathy after induction of general anesthesia].
Topics: Aged; Anesthesia, General; Chronic Disease; Echocardiography; Enema; Female; Fractures, Compression; | 2011 |
Behavior of poly(glycerol sebacate) plugs in chronic tympanic membrane perforations.
Topics: Animals; Chinchilla; Chronic Disease; Decanoates; Glycerol; Humans; Materials Testing; Polymers; Pro | 2012 |
Polyox and carrageenan based composite film dressing containing anti-microbial and anti-inflammatory drugs for effective wound healing.
Topics: Adhesiveness; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Infections; | 2013 |
Microdialysate metabolites before, during and after vascular surgery for chronic leg ischaemia.
Topics: Aged; Aged, 80 and over; Chronic Disease; Female; Glucose; Glycerol; Humans; Ischemia; Lactates; Leg | 2003 |
An effective conservative treatment for chronic sinusitis.
Topics: Chronic Disease; Glycerol; Humans; Quaternary Ammonium Compounds; Sinusitis; Treatment Outcome | 1952 |
High-resolution ultrasound and magnetic resonance imaging to document tissue repair after prolotherapy: a report of 3 cases.
Topics: Adolescent; Adult; Anesthetics, Local; Ankle Injuries; Athletic Injuries; Chronic Disease; Female; G | 2008 |
Management of the ear canal seborrhea with cerumen.
Topics: Cerumen; Child; Chronic Disease; Dermatitis, Seborrheic; Ear Canal; Glycerol; Humans; Infant; Recurr | 1981 |
Recent advances in neurosurgical treatment of chronic pain.
Topics: Chronic Disease; Cordotomy; Electric Stimulation Therapy; Glycerol; Humans; Pain; Pain Management; S | 1980 |
Norepinephrine-stimulated lipolysis in acute and chronic hypoxemia.
Topics: Acute Disease; Animals; Chronic Disease; Dogs; Fatty Acids, Nonesterified; Glycerol; Hypoxia; Lipid | 1981 |
The relationship between the degree of chronic middle ear inflammation and tympanic bulla pneumatization in the pig as animal model.
Topics: Animals; Bone Resorption; Cefamandole; Chronic Disease; Dibekacin; Disease Models, Animal; Ear, Midd | 1994 |
Induction of clusterin in acute and chronic oxidative renal disease in the rat and its dissociation from cell injury.
Topics: Acute Disease; Acute Kidney Injury; Animals; Cells, Cultured; Chronic Disease; Clusterin; Glycerol; | 1994 |
Chronic venous insufficiency.
Topics: Bandages; Chronic Disease; Drug Therapy, Combination; Edema; Gelatin; Glycerol; Humans; Venous Insuf | 1994 |
Edema control in the management of disabling chronic venous insufficiency.
Topics: Administration, Topical; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Bandages; Child; C | 1994 |
Effects of chronic hypercortisolemia on carbohydrate metabolism during insulin deficiency.
Topics: Alanine; Animals; Blood Glucose; Carbohydrate Metabolism; Catecholamines; Chronic Disease; Dogs; Glu | 1994 |
Metabolic responses to graded exercise in chronic heart failure.
Topics: Aged; Blood Glucose; Chronic Disease; Epinephrine; Exercise Test; Fatty Acids, Nonesterified; Female | 1993 |
Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration.
Topics: Acute Disease; Animals; Capsid; Capsid Proteins; Chronic Disease; Cisplatin; Epidermal Growth Factor | 1993 |
Renal phospholipid metabolism in streptozotocin-induced diabetic rats.
Topics: Acute Disease; Analysis of Variance; Animals; Blood Glucose; Body Weight; Chronic Disease; Diabetes | 1996 |
Glycerol gangliotomy of the second dorsal cervical root in rats: an experimental study to evaluate a minimal invasive approach for the treatment of the chronic cervicogenic headache.
Topics: Animals; Chronic Disease; Ganglia, Spinal; Glycerol; Headache; Immunohistochemistry; Injections; Nec | 1998 |
Renal response to repetitive exposure to heme proteins: chronic injury induced by an acute insult.
Topics: Acute Disease; Animals; Chemokine CCL2; Chronic Disease; Collagen; Creatinine; Glycerol; Hemeprotein | 2000 |
Efficacy of a skin-protective foam in the treatment of chronic hand dermatitis.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Chronic Disease; Dermatitis, Contact; Derm | 2000 |
Effects of chronic graded ethanol consumption on the metabolism, ultrastructure, and mechanical function of the rat heart.
Topics: Adenosine Triphosphatases; Animals; Catecholamines; Chronic Disease; Ethanol; Glycerol; Heart; Heart | 1975 |
Curent concepts in primary angle-closure glaucoma.
Topics: Acetazolamide; Acute Disease; Chronic Disease; Glaucoma; Glycerol; Humans; Mannitol; Moxisylyte | 1977 |
[Serum lipid group response after intralipid loading].
Topics: Adult; Aged; Cholesterol; Chromatography, Thin Layer; Chronic Disease; Coronary Disease; Dietary Fat | 1978 |
Identification of some abnormal metabolites in plasma from uremic subjects.
Topics: Autoanalysis; Chromatography, Gas; Chromatography, Gel; Chronic Disease; Erythritol; Glycerol; Human | 1975 |
[The effect of glycerol on local cerebral blood flow in patients with chronic ischemic cerebrovascular lesions].
Topics: Adult; Aged; Brain Ischemia; Cerebrovascular Circulation; Chronic Disease; Female; Glycerol; Humans; | 1991 |
Trigeminal cisternal injection of glycerol for treatment of chronic intractable cluster headaches.
Topics: Adult; Chronic Disease; Cluster Headache; Female; Glycerol; Humans; Injections; Male; Middle Aged; T | 1991 |
[Chronic gastritic changes induced in rats after pyloromyotomy and per os administration of acetic acid-glycerin].
Topics: Acetates; Animals; Chronic Disease; Gastric Mucosa; Gastritis; Glycerol; Male; Pylorus; Rats; Rats, | 1990 |
[Chronic subdural hematoma occurring in patients with senile dementia: report of 4 cases].
Topics: Aged; Aged, 80 and over; Chronic Disease; Dementia; Diagnosis, Differential; Glycerol; Hematoma, Sub | 1989 |
Retro-Gasserian glycerol injection in the treatment of chronic cluster headache.
Topics: Adult; Chronic Disease; Cluster Headache; Face; Glycerol; Humans; Injections; Male; Middle Aged; Sen | 1987 |
[Studies on the composition of liver lipids in chronic experimental diabetes].
Topics: Alcohol Oxidoreductases; Animals; Carbon Isotopes; Chronic Disease; Diabetes Mellitus; Fatty Acids, | 1972 |
Adipose tissue lipolysis in golden hamsters with chronic hypoglycemia and hyperinsulinemia due to a transplantable islet cell tumor.
Topics: Adenoma, Islet Cell; Adipose Tissue; Animal Nutritional Physiological Phenomena; Animals; Antigens; | 1970 |
Effect of acetazolamide on the insulin response to intravenous administration of secretin.
Topics: Acetazolamide; Antigens; Bicarbonates; Blood Glucose; Chronic Disease; Drug Synergism; Duodenum; Fat | 1974 |
[Staphyloimmunocide in the therapy of chronic ulcerative pyoderma].
Topics: Anti-Bacterial Agents; Antiviral Agents; Calcium; Chronic Disease; Drug Combinations; Gluconates; Gl | 1973 |
Metabolic changes in active chronic hepatitis.
Topics: Adult; Aged; Autoantibodies; Autoimmune Diseases; Blood Glucose; Carbohydrate Metabolism; Chronic Di | 1972 |
Absorption and metabolism of D(--) fructose in man.
Topics: Adult; Aged; Arteriosclerosis; Chronic Disease; Coronary Disease; Female; Fructose; Glycerol; Humans | 1971 |
Resistance to glycerol induced hemoglobinuric acute renal failure.
Topics: Acute Kidney Injury; Animals; Chronic Disease; Disease Models, Animal; Diuresis; Female; Glycerol; H | 1970 |
Influence of drugs on aqueous flow in chronic simple glaucoma.
Topics: Acetazolamide; Adult; Aqueous Humor; Chronic Disease; Female; Glaucoma; Glycerol; Humans; Intraocula | 1968 |
Medical treatment of corneal edema.
Topics: Acute Disease; Adrenal Cortex Hormones; Ascorbic Acid; Burns, Chemical; Chronic Disease; Contact Len | 1968 |
[Effect of antidiabetics on the fat metabolism of alloxan-diabetic rats].
Topics: Animals; Chronic Disease; Depression, Chemical; Diabetes Mellitus, Experimental; Fatty Acids, Nonest | 1969 |